We study mechanisms that encourage manufacturers of global health products to build production capacity. This is particularly important for health products manufactured for low- and middle-income country (LMIC) markets where willingness to pay is lower and demand risks are greater. As a result,...

The World Health Organization estimates that almost a third of the world’s population still lacks access to essential medicines. The distribution network for medicines is ineffective and inefficient in many developing countries. Discussions often centre on why the medicines supply chain cannot...